Where does Apollo Endosurgery US, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Apollo Endosurgery US, Inc. ranks #9,183 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Apollo Endosurgery US, Inc. hold?

Apollo Endosurgery US, Inc. holds 34 US utility patents granted between 2017 and 2023, spanning 4 technology areas.

What is Apollo Endosurgery US, Inc.'s Innovation Score?

Apollo Endosurgery US, Inc. has an Innovation Score of 32.8 out of 100 (42nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Apollo Endosurgery US, Inc. focus on?

Apollo Endosurgery US, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 20 patents, ranking #898 of 7,127 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Apollo Endosurgery US, Inc.'s patent grant rate increasing or decreasing?

Apollo Endosurgery US, Inc.'s recent grant velocity is -30% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Apollo Endosurgery US, Inc.'s patents?

Apollo Endosurgery US, Inc.'s patents average 16.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Apollo Endosurgery US, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Apollo Endosurgery US, Inc.

USPTO PatentsView assignee record - 34 granted patents across 4 technology areas, recorded in grant years 2017–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Apollo ranks #9,183 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 4 technology areas.

#9,183
of 49,997 US assignees by volume: 42nd percentile
by Innovation Score (32.8/100): 16.9
avg claims per patent: -30%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9183 · US Corporation #9,183 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 34 grants
UPPER-Q #9,183/49,997
PHOTO-FINISH Adeia Media Holdings
CPC-NARROW A61B · 4 areas
INNOV-THIN 32.8/100
CLAIMS-RICH 16.9 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -30% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Adeia Media Holdings LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Apollo’s 32.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.3 pts (38%) Velocity 3.3 pts (10%) Breadth 7.1 pts (22%) Claim depth 10.1 pts (31%)

Qualcomm Incorporated · highest

85
AgaMatrix · near

33
Apollo Endosurgery US · this assignee

33
Beijing Kohler · near

33
GBS Commonwealth · near

33
Soroco Private · near

33
3D Lighting… · lowest

7

What this shows Apollo's Innovation Score is 32.8/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Apollo?

Each dot is one of Apollo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Apollo’s own 16.9 claims/patent is ABOVE the 15.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Apollo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Apollo's grants concentrate

Apollo Endosurgery US, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 58.8% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (9 grants) versus a trough of 3 in 2020. By volume, Apollo sits between Azionaria Costruzioni Macchine Automatiche A.C.M.A. S.P.A. and Biomadison, Inc..

Apollo's three-year grant acceleration

Apollo Endosurgery US, Inc. shows 6 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Azionaria Costruz…

34
Adeia Media Holdi…

34
Aesynt Incorporat…

34
Alto-shaam

34
Ariens

34
Asana Biosciences

34
BIG Heart PET

34
Biomadison

34
Apollo Endosurger… ◀

34

What this shows Apollo holds 34 patents at rank #9,192, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Apollo

By rank, the assignees closest to #9,192 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Apollo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Apollo, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Apollo ranks #898 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (33 here).

AgaMatrix, Inc. 33 Beijing Kohler Ltd. 33 Soroco Private Limited 33 GBS Commonwealth Co., Ltd. 33

Apollo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 42nd percentile higher than 42% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Apollo Endosurgery US, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	7	20.6%
2018	9	26.5%
2019	4	11.8%
2020	3	8.8%
2021	5	14.7%
2023	6	17.6%

Which technologies does Apollo Endosurgery US, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 20

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 19

Y10T - Technical Subjects Covered BY Former US Classification 4

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Apollo Endosurgery US, Inc.'s patent record in context - here's where to go next.

Apollo Endosurgery US, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 58.8% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #9,183 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Apollo Endosurgery US, Inc. against Azionaria Costruzioni Macchine Automatiche A.C.M.A. S.P.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.